Nebivolol or Metoprolol in Arterial Occlusive Disease: A double-blind, randomised controlled trial.
Phase of Trial: Phase II
Latest Information Update: 06 Jun 2011
At a glance
- Drugs Metoprolol; Nebivolol
- Indications Essential hypertension; Peripheral arterial occlusive disorders
- Focus Pharmacodynamics
- Acronyms NORMA
- Sponsors Berlin Chemie
- 06 Jun 2011 Results published in the Hypertension.
- 06 Jun 2011 Status changed from recruiting to completed.
- 25 Jun 2010 Planned end date (1 Apr 2010) added as reported by ISRCTN: Current Controlled Trials record.